In vitro degradation and release characteristics of biodegradable implants containing trypsin inhibitor

K. A. Athanasiou, A. R. Singhal, C. M. Agrawal, B. D. Boyan

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The use of a biodegradable implant system that provides a steady, controlled release of drugs or bioactive factors can be an attractive delivery vehicle of substances that can enhance repair processes in the musculoskeletal system. The present in vitro study examined the degradative characteristics and release kinetics of a 50 to 50 polylactic acid/polyglycolic acid implant, used as a carrier of trypsin inhibitor, during a 10-week period. Morphological and scanning electron microscopic examinations demonstrated that the implant degraded in a gradual, extended fashion such that by 10 weeks the implant was completely dissolved. It also was shown that the protein was released from the implant in a sigmoidal fashion with increased release between 3 and 7 weeks. More than 95% of the trypsin inhibitor originally incorporated in the implants was released during the 10-week test period. To describe further the degradation process of the implant, temporal changes in its molecular weight and surface axial strain were determined also. It was shown that in the initial 4 weeks, there was a marked decrease in molecular weight of the implants. Axial strain decreased and then increased over time, suggesting an initial period of stiffening followed by a period of degradative softening.

Original languageEnglish (US)
Pages (from-to)272-281
Number of pages10
JournalClinical Orthopaedics and Related Research
Issue number315
StatePublished - 1995

Fingerprint

Absorbable Implants
Trypsin Inhibitors
Molecular Weight
Polyglycolic Acid
Musculoskeletal System
Electrons
Proteins
In Vitro Techniques

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

In vitro degradation and release characteristics of biodegradable implants containing trypsin inhibitor. / Athanasiou, K. A.; Singhal, A. R.; Agrawal, C. M.; Boyan, B. D.

In: Clinical Orthopaedics and Related Research, No. 315, 1995, p. 272-281.

Research output: Contribution to journalArticle

Athanasiou, K. A. ; Singhal, A. R. ; Agrawal, C. M. ; Boyan, B. D. / In vitro degradation and release characteristics of biodegradable implants containing trypsin inhibitor. In: Clinical Orthopaedics and Related Research. 1995 ; No. 315. pp. 272-281.
@article{5d466198c06744099b64ac6d2cd6f194,
title = "In vitro degradation and release characteristics of biodegradable implants containing trypsin inhibitor",
abstract = "The use of a biodegradable implant system that provides a steady, controlled release of drugs or bioactive factors can be an attractive delivery vehicle of substances that can enhance repair processes in the musculoskeletal system. The present in vitro study examined the degradative characteristics and release kinetics of a 50 to 50 polylactic acid/polyglycolic acid implant, used as a carrier of trypsin inhibitor, during a 10-week period. Morphological and scanning electron microscopic examinations demonstrated that the implant degraded in a gradual, extended fashion such that by 10 weeks the implant was completely dissolved. It also was shown that the protein was released from the implant in a sigmoidal fashion with increased release between 3 and 7 weeks. More than 95{\%} of the trypsin inhibitor originally incorporated in the implants was released during the 10-week test period. To describe further the degradation process of the implant, temporal changes in its molecular weight and surface axial strain were determined also. It was shown that in the initial 4 weeks, there was a marked decrease in molecular weight of the implants. Axial strain decreased and then increased over time, suggesting an initial period of stiffening followed by a period of degradative softening.",
author = "Athanasiou, {K. A.} and Singhal, {A. R.} and Agrawal, {C. M.} and Boyan, {B. D.}",
year = "1995",
language = "English (US)",
pages = "272--281",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "315",

}

TY - JOUR

T1 - In vitro degradation and release characteristics of biodegradable implants containing trypsin inhibitor

AU - Athanasiou, K. A.

AU - Singhal, A. R.

AU - Agrawal, C. M.

AU - Boyan, B. D.

PY - 1995

Y1 - 1995

N2 - The use of a biodegradable implant system that provides a steady, controlled release of drugs or bioactive factors can be an attractive delivery vehicle of substances that can enhance repair processes in the musculoskeletal system. The present in vitro study examined the degradative characteristics and release kinetics of a 50 to 50 polylactic acid/polyglycolic acid implant, used as a carrier of trypsin inhibitor, during a 10-week period. Morphological and scanning electron microscopic examinations demonstrated that the implant degraded in a gradual, extended fashion such that by 10 weeks the implant was completely dissolved. It also was shown that the protein was released from the implant in a sigmoidal fashion with increased release between 3 and 7 weeks. More than 95% of the trypsin inhibitor originally incorporated in the implants was released during the 10-week test period. To describe further the degradation process of the implant, temporal changes in its molecular weight and surface axial strain were determined also. It was shown that in the initial 4 weeks, there was a marked decrease in molecular weight of the implants. Axial strain decreased and then increased over time, suggesting an initial period of stiffening followed by a period of degradative softening.

AB - The use of a biodegradable implant system that provides a steady, controlled release of drugs or bioactive factors can be an attractive delivery vehicle of substances that can enhance repair processes in the musculoskeletal system. The present in vitro study examined the degradative characteristics and release kinetics of a 50 to 50 polylactic acid/polyglycolic acid implant, used as a carrier of trypsin inhibitor, during a 10-week period. Morphological and scanning electron microscopic examinations demonstrated that the implant degraded in a gradual, extended fashion such that by 10 weeks the implant was completely dissolved. It also was shown that the protein was released from the implant in a sigmoidal fashion with increased release between 3 and 7 weeks. More than 95% of the trypsin inhibitor originally incorporated in the implants was released during the 10-week test period. To describe further the degradation process of the implant, temporal changes in its molecular weight and surface axial strain were determined also. It was shown that in the initial 4 weeks, there was a marked decrease in molecular weight of the implants. Axial strain decreased and then increased over time, suggesting an initial period of stiffening followed by a period of degradative softening.

UR - http://www.scopus.com/inward/record.url?scp=0029041386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029041386&partnerID=8YFLogxK

M3 - Article

C2 - 7634681

AN - SCOPUS:0029041386

SP - 272

EP - 281

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 315

ER -